1st Quarter - Report — CEPHEID for CEPHEID (2011)

Firm

CEPHEID

Client

CEPHEID

Income

—

Expenses

$40,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

See page five Lobbying Issues: Molecular diagnostic tests, Infection control and prevention programs (Multidrug resistant organisms (MDRO)), CDC-related issues (MDRO research and surveillance), Hospital and other provider quality improvement programs CMS-related issues (reimbursement and coverage policies), FDA oversight, Global health funding Comparative effectiveness, Personalized medicine/pharmacogenomics, Veterans Affairs healthcare-related issues HR 436/ S 17, Protect Medical Innovation Act of 2011 HR 488, Save Our Medical Devices Act of 2011 HR 755, Investing in Our Future Act of 2011 HR 965, Preservation of Antibiotics for Medical Treatment Act of 2011 S 660, Preserving Access to Targeted, Individualized, and Effective New Treatments and Services (PATIENTS) Act of 2011

Lobbyist	Covered position, as disclosed
HALLIE CHRISTINE LEWIS	—
MICHELE M SCHOONMAKER	—

Contacted: Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Agency for Healthcare Research & Quality (AHRQ); Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); SENATE; State, Dept of (DOS); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC)

Bills named: H.R. 436 (112th), H.R. 488 (112th), H.R. 755 (112th), H.R. 965 (112th)

Medicare/Medicaid MMM

See page seven Lobbying Issues: Molecular diagnostic tests, Infection control and prevention programs (Multidrug resistant organisms (MDRO)), CDC-related issues (MDRO research and surveillance), Hospital and other provider quality improvement programs CMS-related issues (reimbursement and coverage policies), FDA oversight, Global health funding Comparative effectiveness, Personalized medicine/pharmacogenomics, Veterans Affairs healthcare-related issues HR 436/ S 17, Protect Medical Innovation Act of 2011 HR 488, Save Our Medical Devices Act of 2011 HR 755, Investing in Our Future Act of 2011 HR 965, Preservation of Antibiotics for Medical Treatment Act of 2011 S 660, Preserving Access to Targeted, Individualized, and Effective New Treatments and Services (PATIENTS) Act of 2011

Lobbyist	Covered position, as disclosed
HALLIE CHRISTINE LEWIS	—
MICHELE M SCHOONMAKER	—

Contacted: Agency for Healthcare Research & Quality (AHRQ); Food & Drug Administration (FDA); Natl Institutes of Health (NIH); Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); State, Dept of (DOS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Bills named: H.R. 965 (112th), H.R. 755 (112th), H.R. 436 (112th), H.R. 488 (112th)

Health Issues HCR

See page three Lobbying Issues: Molecular diagnostic tests, Infection control and prevention programs (Multidrug resistant organisms (MDRO)), CDC-related issues (MDRO research and surveillance), Hospital and other provider quality improvement programs CMS-related issues (reimbursement and coverage policies), FDA oversight, Global health funding Comparative effectiveness, Personalized medicine/pharmacogenomics, Veterans Affairs healthcare-related issues HR 436/ S 17, Protect Medical Innovation Act of 2011 HR 488, Save Our Medical Devices Act of 2011 HR 755, Investing in Our Future Act of 2011 HR 965, Preservation of Antibiotics for Medical Treatment Act of 2011 S 660, Preserving Access to Targeted, Individualized, and Effective New Treatments and Services (PATIENTS) Act of 2011

Lobbyist	Covered position, as disclosed
HALLIE CHRISTINE LEWIS	—
MICHELE M SCHOONMAKER	—

Contacted: HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); SENATE; Agency for Healthcare Research & Quality (AHRQ); State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 965 (112th), H.R. 755 (112th), H.R. 436 (112th), H.R. 488 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.